Asia-Pacific Rapid Diagnostic Tests (RDT) Market
Description
The Asia-Pacific rapid diagnostic tests (RDT) market is expected to reach USD 34.02 billion by 2033 from USD 15.78 billion in 2025, growing at a substantial CAGR of 10.1% in the forecast period of 2026 to 2033.
Market Segmentation:
Asia-Pacific Rapid Diagnostic Tests (RDT) Market, By Mode (Professional Rapid Diagnostic Test- Visual Read, OTC (Over-The-Counter) Rapid Diagnostic Test, Professional Rapid Diagnostic Test-Instrument Read, Professional Rapid Molecular Diagnostic Test – Instrument Read), By Modality (Laboratory Based Test, Non-Laboratory Based Test), By Age Group (Adult, Paediatrics), By Diagnostic Approach (In-Vitro Diagnostic (IVD)- Immunoassay / Lateral Flow, Molecular Diagnostic (Md)), By Application Area (Infectious Disease Testing, Cardiology Testing, Pregnancy & Fertility Testing, Drugs Of Abuse Testing, Oncology Testing, Coagulation Testing, Others), By Price Range (Economy, Mid-Range, Premium), By End User (Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings, Research & Academic Institutes, Others), By Business Type (Government Sector, Private Sector) - Industry Trends and Forecast to 2033
Overview of Asia-Pacific Rapid Diagnostic Tests (RDT) Market Dynamics:
Drivers
• Rising disease burden and expanding healthcare access
• Increasing adoption of lateral flow assay and immunology-based rapid test
• Integration of digital health platform with rapid diagnostics for result tracking
• Increasing government initiatives and funding for healthcare screening programs
Restrains
• High cost of advanced rapid diagnostic tests (RDT)
• Short shelf life and stringent storage conditions of RDTS
Opportunities
• Technological advancements driving accuracy and accessibility
• Growth potential in pandemic preparedness and outbreak surveillance program
• Growing over-the-counter (OTC) consumer adoption and retail distribution growth
Challenges
• Regulatory barriers and quality assurance concerns
• Inconsistent quality standards among low-cost test manufacturers
Market Players:
The key market players operating in the Asia-Pacific rapid diagnostic tests (RDT) market are listed below:
• F. Hoffmann‑La Roche Ltd (Switzerland)
• Abbott (U.S.)
• Sysmex Corporation (Japan)
• Danaher Corporation (U.S.)
• Bio‑Rad Laboratories, Inc (U.S.)
• BD (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Siemens Healthcare Private Limited (Germany)
• Meril Diagnostics (India)
• QIAGEN (Netherlands)
• Wondfo (China)
• QuidelOrtho Corporation (U.S.)
• Werfen (Spain/Germany)
• bioMérieux (France)
• Fujirebio (Japan)
• ACCESS BIO (U.S.)
• SD Biosensor, INC (South Korea)
• Trinity Biotech (Ireland)
• J. Mitra & Co. Pvt. Ltd. (India)
• Chembio Diagnostics, Inc. (U.S.)
• GENBODY INC. (South Korea)
• Precision Biomed Pvt Ltd (India)
• BIOGENIX INC. PVT. LTD (India)
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. This report could take up to 20 business days to prepare and deliver.
Market Segmentation:
Asia-Pacific Rapid Diagnostic Tests (RDT) Market, By Mode (Professional Rapid Diagnostic Test- Visual Read, OTC (Over-The-Counter) Rapid Diagnostic Test, Professional Rapid Diagnostic Test-Instrument Read, Professional Rapid Molecular Diagnostic Test – Instrument Read), By Modality (Laboratory Based Test, Non-Laboratory Based Test), By Age Group (Adult, Paediatrics), By Diagnostic Approach (In-Vitro Diagnostic (IVD)- Immunoassay / Lateral Flow, Molecular Diagnostic (Md)), By Application Area (Infectious Disease Testing, Cardiology Testing, Pregnancy & Fertility Testing, Drugs Of Abuse Testing, Oncology Testing, Coagulation Testing, Others), By Price Range (Economy, Mid-Range, Premium), By End User (Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings, Research & Academic Institutes, Others), By Business Type (Government Sector, Private Sector) - Industry Trends and Forecast to 2033
Overview of Asia-Pacific Rapid Diagnostic Tests (RDT) Market Dynamics:
Drivers
• Rising disease burden and expanding healthcare access
• Increasing adoption of lateral flow assay and immunology-based rapid test
• Integration of digital health platform with rapid diagnostics for result tracking
• Increasing government initiatives and funding for healthcare screening programs
Restrains
• High cost of advanced rapid diagnostic tests (RDT)
• Short shelf life and stringent storage conditions of RDTS
Opportunities
• Technological advancements driving accuracy and accessibility
• Growth potential in pandemic preparedness and outbreak surveillance program
• Growing over-the-counter (OTC) consumer adoption and retail distribution growth
Challenges
• Regulatory barriers and quality assurance concerns
• Inconsistent quality standards among low-cost test manufacturers
Market Players:
The key market players operating in the Asia-Pacific rapid diagnostic tests (RDT) market are listed below:
• F. Hoffmann‑La Roche Ltd (Switzerland)
• Abbott (U.S.)
• Sysmex Corporation (Japan)
• Danaher Corporation (U.S.)
• Bio‑Rad Laboratories, Inc (U.S.)
• BD (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Siemens Healthcare Private Limited (Germany)
• Meril Diagnostics (India)
• QIAGEN (Netherlands)
• Wondfo (China)
• QuidelOrtho Corporation (U.S.)
• Werfen (Spain/Germany)
• bioMérieux (France)
• Fujirebio (Japan)
• ACCESS BIO (U.S.)
• SD Biosensor, INC (South Korea)
• Trinity Biotech (Ireland)
• J. Mitra & Co. Pvt. Ltd. (India)
• Chembio Diagnostics, Inc. (U.S.)
• GENBODY INC. (South Korea)
• Precision Biomed Pvt Ltd (India)
• BIOGENIX INC. PVT. LTD (India)
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. This report could take up to 20 business days to prepare and deliver.
Table of Contents
350 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Asia Pacific Rapid Diagnostic Tests (Rdt) Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Primary Interviews With Key Opinion Leaders
- 2.8 Dbmr Market Position Grid
- 2.9 Market Application Coverage Grid
- 2.10 Vendor Share Analysis
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Porter’s Five Forces
- 4.2 Pestel Analysis
- 4.2.1 Political Factors
- 4.2.2 Economic Factors
- 4.2.3 Social Factors
- 4.2.4 Technological Factors
- 4.2.5 Environmental Factors
- 4.2.6 Legal Factors
- 4.2.7 Quality Assurance & Post Market Obligations
- 4.3 Patent Analysis
- 4.3.1 Patent Number And Expiry
- 4.3.2 Country-level Approval
- 4.3.3 List Of Products Reaching Expiry In Next 3 Years
- 4.3.4 Drugs Patent In Specific Countries
- 4.4 Company Evaluation Quadrant
- 4.5 Supply Chain Ecosystem
- 4.5.1 Prominent Companies
- 4.5.2 Small & Medium Size Companies
- 4.5.3 End Users
- 4.6 Top Tests Ranking & Market Opportunity Section
- 4.6.1 China
- 4.6.2 Japan
- 4.6.3 India
- 4.6.4 South Korea
- 4.6.5 Singapore
- 4.6.6 Malaysia
- 4.6.7 Thailand
- 4.6.8 Indonesia
- 4.6.9 Philippines
- 4.6.10 Vietnam
- 4.6.11 Rest Of Asia–pacific
- 4.7 Customer Buying Drivers – Quality, Asp, Speed, Reputation Others
- 4.7.1 Quality
- 4.7.2 Average Selling Price (Asp)
- 4.7.3 Speed
- 4.7.4 Reputation
- 4.7.5 Other Influential Factors
- 4.8 Industry Insights
- 4.8.1 Micro And Macro Economic Factors
- 4.8.2 Microeconomic Factors
- 4.8.3 Macroeconomic Factors
- 4.8.4 Penetration And Growth Prospect Mapping
- 4.8.5 Market Penetration & Growth By Country
- 4.8.6 Based On Mode (Type Of Rapid Diagnostic Test)
- 4.8.7 Based On Diagnostic Approach
- 4.8.8 Based On End‑user
- 4.9 Key Pricing Strategies
- 4.9.1 Strategic Pricing Approaches For Rdts In Apac
- 4.9.2 Interviews With Specialist
- 4.9.3 Market Penetration And Technology Adoption
- 4.10 Growth Drivers And Challenges
- 4.10.1 Pricing And Procurement
- 4.10.2 End-user Preferences And Insights
- 4.10.3 Strategic Implications Derived From Specialist Insights:
- 4.10.4 Analysis And Recommendation
- 4.10.5 Market Analysis
- 4.10.6 Strategic Recommendations
- 4.10.7 Conclusion
- 5 Regulatory Framework
- 5.1 Regulatory Approval Process
- 5.2 General Process Steps (Apac):
- 5.3 Variations By Market
- 5.4 Geographies’ Ease Of Regulatory Approval
- 5.5 Regulatory Approval Pathways
- 5.6 Standard Approval Pathway
- 5.7 Reliance / Abridged Approval Pathway
- 5.8 Expedited / Priority Review Pathway
- 5.9 Emergency Use Authorization (Eua)
- 5.10 Country-specific Pathway Overview
- 5.11 Licensing And Registration
- 5.12 India — Cdsco Licensing & Registration
- 5.13 Singapore — Health Sciences Authority (Hsa)
- 5.14 Australia — Therapeutic Goods Administration (Tga)
- 5.15 Other Apac Markets (Summary)
- 5.16 Post-marketing Surveillance
- 5.17 Good Manufacturing Practices (Gmps) Guidelines
- 6 Epidemiology
- 6.1 Incidence Of All By Gender
- 6.2 Treatment Rate
- 6.3 Mortality Rate
- 6.4 Drug Adherence And Therapy Switch Model
- 6.5 Patient Treatment Success Rates
- 7 Healthcare Tariffs Impact Analysis
- 7.1 Overview
- 7.2 Tariff Structures.
- 7.2.1 Asia-pacific: Government-imposed Tariffs On Imported Medical Products
- 7.2.2 Emerging Markets: Challenges In Tariff Implementation
- 7.3 Pharmaceutical Tariffs And Trade Barriers
- 7.3.1 Import Duties On Prescription Drugs Vs. Generics
- 7.3.2 Impact On Drug Affordability And Access
- 7.3.3 Key Trade Agreements Affecting Pharmaceutical Tariffs
- 7.4 Impact Of Healthcare Tariffs On Providers And Patients
- 7.4.1 Cost Burden On Hospitals And Healthcare Facilities
- 7.4.2 Effect On Patient Affordability And Insurance Coverage
- 7.4.3 Tariffs And Their Role In Medical Tourism
- 7.5 Trade Agreements And Healthcare Tariffs
- 7.5.1 Wto Regulations On Healthcare Tariffs
- 7.5.2 Impact Of Trade Wars On The Healthcare Supply Chain
- 7.5.3 Role Of Free Trade Agreements (Ftas) In Reducing Tariffs
- 7.6 Impact Of Tariffs On Healthcare Costs And Accessibility
- 7.7 Importance Of Tariffs In The Healthcare Sector
- 8 Market Overview
- 8.1 Drivers
- 8.1.1 Rising Disease Burden And Expanding Healthcare Access
- 8.1.2 Increasing Adoption Of Lateral Flow Assay And Immunology Based Rapid Test
- 8.1.3 Integration Of Digital Health Platform With Rapid Diagnostics For Result Tracking
- 8.1.4 Increasing Government Initiatives And Funding For Healthcare Screening Programs
- 8.2 Restraints
- 8.2.1 High Cost Of Advanced Rapid Diagnostic Tests (Rdt)
- 8.2.2 Short Shelf Life And Stringent Storage Conditions Of (Rdts)
- 8.3 Opportunities
- 8.3.1 Technological Advancements Driving Accuracy And Accessibility
- 8.3.2 Growth Potential In Pandemic Preparedness And Outbreak Surveillance Program
- 8.3.3 Growing Over-the-counter (Otc) Consumer Adoption And Retail Distribution Growth
- 8.4 Challenegs
- 8.4.1 Regulatory Barriers And Quality Assurance Concerns
- 8.4.2 Inconsistent Quality Standards Among Low-cost Test Manufacturers
- 9 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Mode
- 9.1 Overview
- 9.2 Professional Rapid Diagnostic Test – Visual Read
- 9.3 Otc (Over-the-counter) Rapid Diagnostic Test
- 9.4 Professional Rapid Diagnostic Test – Instrument Read
- 9.5 Professional Rapid Molecular Diagnostic Test – Instrument Read
- 10 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Modality
- 10.1 Overview
- 10.2 Laboratory Based Test
- 10.3 Non-laboratory Based Test
- 11 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Age Group
- 11.1 Overview
- 11.2 Adult
- 11.3 Pediatrics
- 12 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Diagnostic Approach
- 12.1 Overview
- 12.2 In-vitro Diagnostic (Ivd) – Immunoassay / Lateral Flow
- 12.3 Molecular Diagnostic (Md)
- 12.4 Asia-pacific In-vitro Diagnostic (Ivd) – Immunoassay / Lateral Flow In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- 12.4.1 Lateral Flow Immunoassay (Lfia)
- 12.4.2 Visual Read Rdts (Cassette/Strip Form)
- 12.4.3 Colorimetric
- 12.4.4 Others
- 12.5 Asia-pacific Molecular Diagnostic (Md) In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- 12.5.1 Naat-based Rapid
- 12.5.2 Rapid Pcr
- 12.5.3 Isothermal Amplification
- 12.5.4 Others
- 13 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Application Area
- 13.1 Overview
- 13.2 Infectious Disease Testing
- 13.3 Asia-pacific Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- 13.3.1 Respiratory Infection Tests
- 13.3.2 Hepatitis
- 13.3.3 Hiv
- 13.3.4 Malaria
- 13.3.5 Dengue
- 13.3.6 Sexually Transmitted Diseases
- 13.3.7 Gastrointestinal Infections
- 13.3.8 Chikungunya
- 13.3.9 Others
- 13.4 Asia-pacific Respiratory Infection Tests In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- 13.4.1 Influenza A+B / A+B+C
- 13.4.2 Rsv
- 13.4.3 Strep A
- 13.4.4 Mycoplasma
- 13.4.5 S. Pneumonia
- 13.4.6 Legionella
- 13.4.7 Others
- 13.5 Asia-pacific Sexually Transmitted Diseases In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- 13.5.1 Chlamydia
- 13.5.2 Gonorrhea
- 13.5.3 Syphilis
- 13.5.4 Others
- 13.6 Asia-pacific Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- 13.6.1 H. Pylori Ab/Ag
- 13.6.2 Typhoid
- 13.6.3 Rotavirus
- 13.6.4 C. Difficile
- 13.6.5 E. Coli
- 13.6.6 Norovirus
- 13.6.7 Campylobacter
- 13.6.8 Adenovirus
- 13.6.9 E71
- 13.6.10 Others
- 13.7 Cardiology Testing
- 13.8 Asia-pacific Cardiology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- 13.8.1 Hs-troponin I
- 13.8.2 Bnp / Nt Probnp
- 13.8.3 D Dimer
- 13.8.4 S-troponin T
- 13.8.5 Ck Mb
- 13.8.6 Hscrp
- 13.8.7 Myoglobin
- 13.8.8 Pct
- 13.8.9 St2
- 13.8.10 Homocysteine
- 13.8.11 Galectin 3
- 13.9 Pregnancy & Fertility Testing
- 13.10 Asia-pacific Pregnancy & Fertility Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- 13.10.1 Hcg
- 13.10.2 Lh
- 13.10.3 Combined Fertility Panels
- 13.11 Drugs Of Abuse Testing
- 13.12 Asia-pacific Drugs Of Abuse Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- 13.12.1 Multi-panel Urine Tests
- 13.12.2 Oral Fluid Drug Tests
- 13.13 Oncology Testing
- 13.14 Asia-pacific Oncology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- 13.14.1 Afp
- 13.14.2 Cea
- 13.14.3 Psa
- 13.14.4 Ca19 9
- 13.14.5 Ca125
- 13.14.6 Ca15 3
- 13.14.7 Others
- 13.15 Coagulation Testing
- 13.16 Asia-pacific Coagulation Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- 13.16.1 Pt
- 13.16.2 Ptt
- 13.16.3 Act
- 13.16.4 Fib
- 13.16.5 Tt
- 13.17 Others
- 14 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Price Range
- 14.1 Overview
- 14.2 Economy
- 14.3 Mid-range
- 14.4 Premium
- 15 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By End User
- 15.1 Overview
- 15.2 Hospitals & Clinics
- 15.3 Asia-pacific Hospitals & Clinics In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- 15.3.1 Public
- 15.3.2 Private
- 15.4 Diagnostic Laboratories
- 15.5 Home Care Settings
- 15.6 Research & Academic Institutes
- 15.7 Others
- 16 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Business Type
- 16.1 Overview
- 16.2 Government Sector
- 16.3 Private Sector
- 17 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Country
- 17.1 Asia-pacific
- 17.1.1 China
- 17.1.2 Japan
- 17.1.3 India
- 17.1.4 South Korea
- 17.1.5 Australia
- 17.1.6 Indonesia
- 17.1.7 Thailand
- 17.1.8 Singapore
- 17.1.9 Malaysia
- 17.1.10 Philippines
- 17.1.11 Vietnam
- 17.1.12 Pakistan
- 17.1.13 Bangladesh
- 17.1.14 Sri Lanka
- 17.1.15 Nepal
- 17.1.16 Afghanistan
- 17.1.17 Maldives
- 17.1.18 Bhutan
- 17.1.19 Rest Of Asia-pacific
- 18 Germany Safety Footwear Market, Company Landscape
- 18.1 Asia-pacific Rapid Diagnostic Tests (Rdt) Company Share Analysis: Asia-pacific
- 18.2 Company Share Analysis By Mode
- 18.2.1 Professional Rapid Diagnostic Test – Visual Read
- 18.2.2 Professional Rapid Diagnostic Test – Instrument Read
- 18.2.3 Professional Rapid Molecular Diagnostic Test – Instrument Read
- 18.2.4 Otc (Over-the-counter) Rapid Diagnostic Test
- 19 Swot Analysis
- 20 Company Profile
- 20.1 F. Hoffmann-la Roche Ltd
- 20.1.1 Company Snapshot
- 20.1.2 Revenue Analysis
- 20.1.3 Product Portfolio
- 20.1.4 Recent Deveopment
- 20.2 Abbott
- 20.2.1 Company Snapshot
- 20.2.2 Revenue Analysis
- 20.2.3 Product Portfolio
- 20.2.4 Recent Deveopment
- 20.3 Sysmex Corporation
- 20.3.1 Company Snapshot
- 20.3.2 Revenue Analysis
- 20.3.3 Product Portfolio
- 20.3.4 Recent Deveopment
- 20.4 Danaher Corporation
- 20.4.1 Company Snapshot
- 20.4.2 Revenue Analysis
- 20.4.3 Product Portfolio
- 20.4.4 Recent Development
- 20.5 Thermo Fisher Scientific
- 20.5.1 Company Snapshot
- 20.5.2 Revenue Analysis
- 20.5.3 Product Portfolio
- 20.5.4 Recent Deveopment
- 20.6 Access Bio
- 20.6.1 Company Snapshot
- 20.6.2 Product Portfolio
- 20.6.3 Recent Development
- 20.7 Becton, Dickinson (Bd)
- 20.7.1 Company Snapshot
- 20.7.2 Revenue Analysis
- 20.7.3 Product Portfolio
- 20.7.4 Recent Deveopment
- 20.8 Biogenix Inc. Pvt. Ltd.
- 20.8.1 Company Snapshot
- 20.8.2 Product Portfolio
- 20.8.3 Recent Development
- 20.9 Biosci Healthcare
- 20.9.1 Company Snapshot
- 20.9.2 Product Portfolio
- 20.9.3 Recent Development
- 20.10 Biomerieux
- 20.10.1 Company Snapshot
- 20.10.2 Revenue Analysis
- 20.10.3 Product Portfolio
- 20.10.4 Recent Deveopment
- 20.11 Bio-rad Laboratories, Inc.
- 20.11.1 Company Snapshot
- 20.11.2 Revenue Analysis
- 20.11.3 Product Portfolio
- 20.11.4 Recent Development
- 20.12 Chembio Diagnostics, Inc.
- 20.12.1 Company Snapshot
- 20.12.2 Product Portfolio
- 20.12.3 Recent Development
- 20.13 Fujirebio
- 20.13.1 Company Snapshot
- 20.13.2 Product Portfolio
- 20.13.3 Recent Deveopment
- 20.14 Genbody Inc.
- 20.14.1 Company Snapshot
- 20.14.2 Product Portfolio
- 20.14.3 Recent Development
- 20.15 Intec Products, Inc.
- 20.15.1 Company Snapshot
- 20.15.2 Product Portfolio
- 20.15.3 Recent Development
- 20.16 J. Mitra & Co. Pvt. Ltd.
- 20.16.1 Company Snapshot
- 20.16.2 Product Portfolio
- 20.16.3 Recent Development
- 20.17 Meril Diagnostics
- 20.17.1 Company Snapshot
- 20.17.2 Product Portfolio
- 20.17.3 Recent Development
- 20.18 Precision Biomed Pvt Ltd.
- 20.18.1 Company Snapshot
- 20.18.2 Product Portfolio
- 20.18.3 Recent Development
- 20.19 Qiagen
- 20.19.1 Company Snapshot
- 20.19.2 Revenue Analysis
- 20.19.3 Product Portfolio
- 20.19.4 Recent Deveopment
- 20.20 Quidelortho Corporation
- 20.20.1 Company Snapshot
- 20.20.2 Revenue Analysis
- 20.20.3 Product Portfolio
- 20.20.4 Recent Development
- 20.21 Sd Biosensor, Inc.
- 20.21.1 Company Snapshot
- 20.21.2 Revenue Analysis
- 20.21.3 Product Portfolio
- 20.21.4 Recent Development
- 20.22 Siemens Healthineers
- 20.22.1 Company Snapshot
- 20.22.2 Revenue Analysis
- 20.22.3 Product Portfolio
- 20.22.4 Recent Deveopment
- 20.23 Trinity Biotech
- 20.23.1 Company Snapshot
- 20.23.2 Revenue Analysis
- 20.23.3 Product Portfolio
- 20.23.4 Recent Deveopment
- 20.24 Werfen
- 20.24.1 Company Snapshot
- 20.24.2 Product Portfolio
- 20.24.3 Recent Development
- 20.25 Wondfo
- 20.25.1 Company Snapshot
- 20.25.2 Product Portfolio
- 20.25.3 Recent Development
- 21 Questionnaire
- 22 Related Reports
- List Of Tables
- Table 1 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Mode, 2018-2033 (Usd Thousand)
- Table 2 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Modality, 2018-2033 (Usd Thousand)
- Table 3 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Age Group, 2018-2033 (Usd Thousand)
- Table 4 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Diagnostic Approach, 2018-2033 (Usd Thousand)
- Table 5 Asia-pacific In-vitro Diagnostic (Ivd) – Immunoassay / Lateral Flow In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 6 Asia-pacific Molecular Diagnostic (Md) In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 7 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Application Area, 2018-2033 (Usd Thousand)
- Table 8 Asia-pacific Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 9 Asia-pacific Respiratory Infection Tests In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 10 Asia-pacific Sexually Transmitted Diseases In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 11 Asia-pacific Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 12 Asia-pacific Cardiology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 13 Asia-pacific Pregnancy & Fertility Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 14 Asia-pacific Drugs Of Abuse Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 15 Asia-pacific Oncology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 16 Asia-pacific Coagulation Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 17 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Price Range, 2018-2033 (Usd Thousand)
- Table 18 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By End User, 2018-2033 (Usd Thousand)
- Table 19 Asia-pacific Hospitals & Clinics In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 20 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Business Type, 2018-2033 (Usd Thousand)
- Table 21 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, 2018-2033 (Usd Thousand)
- Table 22 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Country, 2018-2033 (Usd Thousand)
- Table 23 Asia Pacific
- Table 24 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Mode, 2018-2033 (Usd Thousand)
- Table 25 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Modality, 2018-2033 (Usd Thousand)
- Table 26 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Age Group, 2018-2033 (Usd Thousand)
- Table 27 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Diagnostic Approach, 2018-2033 (Usd Thousand)
- Table 28 Asia-pacific In-vitro Diagnostic (Ivd) – Immunoassay / Lateral Flow In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 29 Asia-pacific Molecular Diagnostic (Md) In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 30 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Application Area, 2018-2033 (Usd Thousand)
- Table 31 Asia-pacific Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 32 Asia-pacific Respiratory Infection Tests In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 33 Asia-pacific Sexually Transmitted Diseases In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 34 Asia-pacific Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 35 Asia-pacific Cardiology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 36 Asia-pacific Pregnancy & Fertility Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 37 Asia-pacific Drugs Of Abuse Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 38 Asia-pacific Oncology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 39 Asia-pacific Coagulation Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 40 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Price Range, 2018-2033 (Usd Thousand)
- Table 41 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By End User, 2018-2033 (Usd Thousand)
- Table 42 Asia-pacific Hospitals & Clinics In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 43 Asia-pacific Rapid Diagnostic Tests (Rdt) Market, By Business Type, 2018-2033 (Usd Thousand)
- Table 44 China Rapid Diagnostic Tests (Rdt) Market, By Mode, 2018-2033 (Usd Thousand)
- Table 45 China Rapid Diagnostic Tests (Rdt) Market, By Modality, 2018-2033 (Usd Thousand)
- Table 46 China Rapid Diagnostic Tests (Rdt) Market, By Age Group, 2018-2033 (Usd Thousand)
- Table 47 China Rapid Diagnostic Tests (Rdt) Market, By Diagnostic Approach, 2018-2033 (Usd Thousand)
- Table 48 China In-vitro Diagnostic (Ivd) – Immunoassay / Lateral Flow In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 49 China Molecular Diagnostic (Md) In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 50 China Rapid Diagnostic Tests (Rdt) Market, By Application Area, 2018-2033 (Usd Thousand)
- Table 51 China Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 52 China Respiratory Infection Tests In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 53 China Sexually Transmitted Diseases In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 54 China Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 55 China Cardiology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 56 China Pregnancy & Fertility Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 57 China Drugs Of Abuse Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 58 China Oncology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 59 China Coagulation Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 60 China Rapid Diagnostic Tests (Rdt) Market, By Price Range, 2018-2033 (Usd Thousand)
- Table 61 China Rapid Diagnostic Tests (Rdt) Market, By End User, 2018-2033 (Usd Thousand)
- Table 62 China Hospitals & Clinics In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 63 China Rapid Diagnostic Tests (Rdt) Market, By Business Type, 2018-2033 (Usd Thousand)
- Table 64 Japan Rapid Diagnostic Tests (Rdt) Market, By Mode, 2018-2033 (Usd Thousand)
- Table 65 Japan Rapid Diagnostic Tests (Rdt) Market, By Modality, 2018-2033 (Usd Thousand)
- Table 66 Japan Rapid Diagnostic Tests (Rdt) Market, By Age Group, 2018-2033 (Usd Thousand)
- Table 67 Japan Rapid Diagnostic Tests (Rdt) Market, By Diagnostic Approach, 2018-2033 (Usd Thousand)
- Table 68 Japan In-vitro Diagnostic (Ivd) – Immunoassay / Lateral Flow In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 69 Japan Molecular Diagnostic (Md) In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 70 Japan Rapid Diagnostic Tests (Rdt) Market, By Application Area, 2018-2033 (Usd Thousand)
- Table 71 Japan Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 72 Japan Respiratory Infection Tests In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 73 Japan Sexually Transmitted Diseases In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 74 Japan Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 75 Japan Cardiology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 76 Japan Pregnancy & Fertility Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 77 Japan Drugs Of Abuse Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 78 Japan Oncology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 79 Japan Coagulation Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 80 Japan Rapid Diagnostic Tests (Rdt) Market, By Price Range, 2018-2033 (Usd Thousand)
- Table 81 Japan Rapid Diagnostic Tests (Rdt) Market, By End User, 2018-2033 (Usd Thousand)
- Table 82 Japan Hospitals & Clinics In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 83 Japan Rapid Diagnostic Tests (Rdt) Market, By Business Type, 2018-2033 (Usd Thousand)
- Table 84 India Rapid Diagnostic Tests (Rdt) Market, By Mode, 2018-2033 (Usd Thousand)
- Table 85 India Rapid Diagnostic Tests (Rdt) Market, By Modality, 2018-2033 (Usd Thousand)
- Table 86 India Rapid Diagnostic Tests (Rdt) Market, By Age Group, 2018-2033 (Usd Thousand)
- Table 87 India Rapid Diagnostic Tests (Rdt) Market, By Diagnostic Approach, 2018-2033 (Usd Thousand)
- Table 88 India In-vitro Diagnostic (Ivd) – Immunoassay / Lateral Flow In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 89 India Molecular Diagnostic (Md) In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 90 India Rapid Diagnostic Tests (Rdt) Market, By Application Area, 2018-2033 (Usd Thousand)
- Table 91 India Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 92 India Respiratory Infection Tests In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 93 India Sexually Transmitted Diseases In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 94 India Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 95 India Cardiology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 96 India Pregnancy & Fertility Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 97 India Drugs Of Abuse Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 98 India Oncology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 99 India Coagulation Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 100 India Rapid Diagnostic Tests (Rdt) Market, By Price Range, 2018-2033 (Usd Thousand)
- Table 101 India Rapid Diagnostic Tests (Rdt) Market, By End User, 2018-2033 (Usd Thousand)
- Table 102 India Hospitals & Clinics In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 103 India Rapid Diagnostic Tests (Rdt) Market, By Business Type, 2018-2033 (Usd Thousand)
- Table 104 South Korea Rapid Diagnostic Tests (Rdt) Market, By Mode, 2018-2033 (Usd Thousand)
- Table 105 South Korea Rapid Diagnostic Tests (Rdt) Market, By Modality, 2018-2033 (Usd Thousand)
- Table 106 South Korea Rapid Diagnostic Tests (Rdt) Market, By Age Group, 2018-2033 (Usd Thousand)
- Table 107 South Korea Rapid Diagnostic Tests (Rdt) Market, By Diagnostic Approach, 2018-2033 (Usd Thousand)
- Table 108 South Korea In-vitro Diagnostic (Ivd) – Immunoassay / Lateral Flow In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 109 South Korea Molecular Diagnostic (Md) In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 110 South Korea Rapid Diagnostic Tests (Rdt) Market, By Application Area, 2018-2033 (Usd Thousand)
- Table 111 South Korea Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 112 South Korea Respiratory Infection Tests In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 113 South Korea Sexually Transmitted Diseases In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 114 South Korea Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 115 South Korea Cardiology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 116 South Korea Pregnancy & Fertility Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 117 South Korea Drugs Of Abuse Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 118 South Korea Oncology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 119 South Korea Coagulation Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 120 South Korea Rapid Diagnostic Tests (Rdt) Market, By Price Range, 2018-2033 (Usd Thousand)
- Table 121 South Korea Rapid Diagnostic Tests (Rdt) Market, By End User, 2018-2033 (Usd Thousand)
- Table 122 South Korea Hospitals & Clinics In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 123 South Korea Rapid Diagnostic Tests (Rdt) Market, By Business Type, 2018-2033 (Usd Thousand)
- Table 124 Australia Rapid Diagnostic Tests (Rdt) Market, By Mode, 2018-2033 (Usd Thousand)
- Table 125 Australia Rapid Diagnostic Tests (Rdt) Market, By Modality, 2018-2033 (Usd Thousand)
- Table 126 Australia Rapid Diagnostic Tests (Rdt) Market, By Age Group, 2018-2033 (Usd Thousand)
- Table 127 Australia Rapid Diagnostic Tests (Rdt) Market, By Diagnostic Approach, 2018-2033 (Usd Thousand)
- Table 128 Australia In-vitro Diagnostic (Ivd) – Immunoassay / Lateral Flow In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 129 Australia Molecular Diagnostic (Md) In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 130 Australia Rapid Diagnostic Tests (Rdt) Market, By Application Area, 2018-2033 (Usd Thousand)
- Table 131 Australia Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 132 Australia Respiratory Infection Tests In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 133 Australia Sexually Transmitted Diseases In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 134 Australia Infectious Disease Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 135 Australia Cardiology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 136 Australia Pregnancy & Fertility Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 137 Australia Drugs Of Abuse Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 138 Australia Oncology Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 139 Australia Coagulation Testing In Rapid Diagnostic Tests (Rdt) Market, By Type, 2018-2033 (Usd Thousand)
- Table 140 Australia Rapid Diagnostic Tests (Rdt) Market, By Price Range, 2018-2033 (Usd Thousand)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
